Printer Friendly

ROBERTS PHARMACEUTICAL COMMENCES PUBLIC OFFERING OF 2.5 MILLION SHARES OF COMMON STOCK

 EATONTOWN, N.J., Sept. 28 /PRNewswire/ -- Roberts Pharmaceutical Corporation (NASDAQ: RPCX) announced today the commencement of a public offering of 2.5 million shares of common stock at a price of $31-3/4 per share through an underwriting group managed by Morgan Stanley & Co. Incorporated and Merrill Lynch & Co.
 Yamanouchi Pharmaceutical Co. Ltd., the company's largest shareholder, has agreed to purchase 800,000 shares of common stock from Roberts subject to and contemporaneous with the public offering at a per share price equal to the public offering price less underwriting discounts and commissions.
 Proceeds to the company from the sale of its shares will be used for general corporate purposes, including repayment of debt attributable to product acquisitions, payments for products acquired or expected to be acquired by the Company in 1993, working capital and possible future acquisitions of compatible products or businesses.
 Roberts Pharmaceutical Corporation is an international pharmaceutical company focusing on the acquisition and development of late-stage development products and the acquisition of currently marketed prescription and nonprescription products. Roberts currently markets its products in seven countries and has operating subsidiaries in the United States, Canada and the United Kingdom. Roberts has six prescription pharmaceutical products in late-stage clinical development and currently markets products primarily in six major therapeutic areas: Cardiovascular, Respiratory, Gynecology/Endocrinology, Urology, Oncology and Gastroenterology.
 A copy of the prospectus relating to the public offering can be obtained from Morgan Stanley & Co. Incorporated, 1251 Avenue of the Americas, N.Y., N.Y., 10020.
 -0- 9/28/93
 /CONTACT: Anthony P. Maris of Roberts Pharmaceutical, 908-389-1182/
 (RPCX)


CO: Roberts Pharmaceuticals Corporation ST: New Jersey IN: MTC SU: OFR

PS -- NY022 -- 6243 09/28/93 09:05 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 28, 1993
Words:281
Previous Article:BED BATH & BEYOND INC. REPORTS SEPTEMBER 1993 SALES
Next Article:A&A LIKELY TO REPORT THIRD QUARTER LOSS; IN ADDITION, UNDERSTANDING IS REACHED ON TERMS FOR SETTLING IRS CLAIMS
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters